Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revolutionizing cancer treatment: a comprehensive review of CAR-T cell therapy
Preeti Dabas, Adithi Danda
Medical Oncology (2023) Vol. 40, Iss. 9
Closed Access | Times Cited: 17

Showing 17 citing articles:

Heterogeneity of the tumor immune cell microenvironment revealed by single-cell sequencing in head and neck cancer
Chunhong Li, Jia Liao, Bo Chen, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 209, pp. 104677-104677
Open Access | Times Cited: 1
MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV
Sergio P. Alpuche-Lazcano, Robert J. Scarborough, Anne Gatignol
Retrovirology (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up
Mohamed Elmarasi, Islam Elkonaissi, Ahmed Elsabagh, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112312-112312
Open Access | Times Cited: 4
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
Eleonora Pinto, Lisa A. Lione, Mirco Compagnone, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Therapeutic role of immune cells against colon cancer
Manoj Kumar Gupta, Gayatri Gouda, Ramakrishna Vadde
Elsevier eBooks (2025), pp. 127-146
Closed Access
Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm
Giuseppe A. Ramirez, Chiara Cardamone, Sara Lettieri, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity
Sara Caratelli, Francesca De Paolis, Domenico Alessandro Silvestris, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy
Alicia Arroyo-Nogales, Guillermo Plaza-Palomo, Javier Gónzalez‐Larre, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1257-1257
Open Access
Engineered Proteins and Chemical Tools to Probe the Cell Surface Proteome
Kevin K. Leung, Kaitlin Schaefer, Zhi Lin, et al.
Chemical Reviews (2025)
Open Access
An Inhaled Nanoemulsion Encapsulating a Herbal Drug for Non-Small Cell Lung Cancer (NSCLC) Treatment
Mural Quadros, Mimansa Goyal, Gautam Chauhan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 540-540
Open Access
Next-generation cancer treatment: exploring the tumor microenvironment and CAR-T cell therapy potential
Muhammadul-Awwal Irodatullah Bisola, Ikponmwosa Jude Ogieuhi, Victor Oluwatomiwa Ajekiigbe, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
The biological and sociological implications of diversity, equity, and inclusion (DEI): life within microbiomes and on earth
David A. Lawrence, Brandon O’Sullivan, Joerg Graf, et al.
Journal of Toxicology and Environmental Health Part B (2025), pp. 1-9
Closed Access
New Challenging Systemic Therapies for Juvenile Scleroderma: A Comprehensive Review
Chiara Sassetti, Claudia Borrelli, Martha Mazuy, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 5, pp. 643-643
Open Access
CAR-T Cell Therapy for Cancer
Ismail Ibrahim Al-Janabi
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 6, Iss. 2, pp. 21-31
Open Access | Times Cited: 3
The evolution and ongoing challenge of unproven cell-based interventions
Taylor N Brinsfield, Noah R Pinson, Aaron Levine
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 9, pp. 851-858
Open Access | Times Cited: 1
B7-H3 in glioblastoma and beyond: significance and therapeutic strategies
Dušan Babić, Ivana Jovčevska, Alja Zottel
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Examining the effect of activated cytotoxic (CD8+) T-cell exosomes to the lung cancer
Eldar Sovunjov, Zehra Seda Halbutoğulları, Gülçin Gacar, et al.
Medical Oncology (2023) Vol. 40, Iss. 12
Closed Access | Times Cited: 2
Preclinical delayed toxicity studies of BCMA CAR T-cell injection in B-NDG mice with multiple myeloma
Jianmin Guo, Qiqi Wu, Hongjian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The CD64/CD28/CD3 ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity
Sara Caratelli, Francesca De Paolis, Domenico Alessandro Silvestris, et al.
(2024)
Closed Access
Current Progress of CAR-T Cell Therapy in Lung Cancer
Jingzhao Lou
Highlights in Science Engineering and Technology (2024) Vol. 102, pp. 492-498
Closed Access
Tagging CAR-T cells to enable control and quantitative imaging
Peter L. Choyke, Orit Jacobson, Noriko Sato
Molecular Therapy (2023) Vol. 31, Iss. 12, pp. 3369-3370
Open Access
Page 1

Scroll to top